ACTH 4-10 in the amelioration of neuropsychological symptomatology associated with senile organic brain syndrome.
Eighteen male and female volunteers over the age of sixty who exhibited mild senile organic brain syndrome were administered ACTH 4-10 (Org OI 63) (30 mg, s.c.) or saline in a 2 X 2 Latin square design. Subjects experienced a reduction in depression and confusion and an increase in vigor. This evidence of an increase in vigor was supported behaviorally by a delay in the onset of increased latency in reaction time. Data also indicated that retrieval from memory may be enhanced by this compound. The electroencephalogram evinced a shift to lower frequencies under ACTH 4-10, but this effect was primarily noted in the females who received drug followed by placebo. These effects of ACTH 4-10 are intriguing and suggest that further work in this area should be encouraged.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000368:Aged; D002986:Clinical Trials as Topic; D003704:Dementia / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D004569:Electroencephalography; D004644:Emotions / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008568:Memory / Q000187:drug effects; D008875:Middle Aged; D010446:Peptide Fragments / Q000627:therapeutic use; D010465:Perception / Q000187:drug effects; D011930:Reaction Time / Q000187:drug effects; D013997:Time Factors
D010446:Peptide Fragments; D000324:Adrenocorticotropic Hormone